We were unable to recruit noncontroller participants with untreated chronic HIV infection, but it will be important for future studies to investigate HIV-specific CD8+ T cell responses in LN following treatment interruption in individuals who succeed or fail in achieving post-treatment control of viremia. This evidence concerns the gene CD8A and HIV infectious disease.